Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haematopoietic Stem Cell Transplant, Allogeneic”

562 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 562 results

Testing effectiveness (Phase 2)WithdrawnNCT00728585
What this trial is testing

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Who this might be right for
Gastrointestinal MucositisMalignant Neoplasm
Children's Oncology Group
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Not applicableUnknownNCT04281797
What this trial is testing

Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients

Who this might be right for
Transplantation InfectionKidney Transplant; ComplicationsStem Cell Transplant Complications+2 more
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 90
Not applicableActive Not RecruitingNCT03965429
What this trial is testing

Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Malignant Hemopathy
Institut Paoli-Calmettes 1,020
Not applicableNot Yet RecruitingNCT07552480
What this trial is testing

Clinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell Transplantation in Patients With Malignant Hematologic Diseases Using Goserelin

Who this might be right for
Allogeneic Haematopoietic Stem Cell TransplantationMalignant Hematologic DiseaseOvarian Insufficiency
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 64
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Not applicableStudy completedNCT01879072
What this trial is testing

Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Medical College of Wisconsin 1,860
Testing effectiveness (Phase 2)Looking for participantsNCT06619561
What this trial is testing

Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Who this might be right for
Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC 48
Testing effectiveness (Phase 2)Looking for participantsNCT04339777
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Who this might be right for
Lymphoproliferative DisordersAutoimmune LymphoproliferativeImmune System Diseases+2 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT01349101
What this trial is testing

A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78
Not applicableStudy completedNCT04888286
What this trial is testing

DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors

Who this might be right for
Hematologic DiseasesStem Cell Transplant Complications
Gruppo Italiano Trapianto di Midollo Osseo 912
Early research (Phase 1)Study completedNCT02805075
What this trial is testing

Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmRecurrent Hematologic Malignancy
Stanford University 15
Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544466
What this trial is testing

Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 75
Testing effectiveness (Phase 2)UnknownNCT01549665
What this trial is testing

Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease

Who this might be right for
Graft-Versus-Host DiseaseGVHDAllogeneic Hematopoietic Transplant+1 more
Samsung Medical Center 30
Not applicableUnknownNCT06075212
What this trial is testing

Immune Reconstitution After Allo-HSCT and Blinatumomab

Who this might be right for
Leukemia, Lymphoid
Sichuan University 20
Large-scale testing (Phase 3)UnknownNCT03371667
What this trial is testing

To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids

Who this might be right for
Allogeneic DiseaseGVH - Graft Versus Host ReactionGVHD, Acute+1 more
Assistance Publique - Hôpitaux de Paris 102
Large-scale testing (Phase 3)Study completedNCT04167514
What this trial is testing

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Who this might be right for
Graft Versus Host Disease (GVHD)
CSL Behring 136
Testing effectiveness (Phase 2)Study completedNCT01036009
What this trial is testing

Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+7 more
University of California, San Francisco 43
Load More Results